Paper11073754
Susceptibility testing for mycobacteria.
Woods GL. Clin Infect Dis, 2000. Cited by 121 papers, by iCite.
Cite this record
ConductScience Library. Susceptibility testing for mycobacteria. Papers, record 11073754. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/11073754
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics4
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Microbial Sensitivity Tests | Major topic |
| Mycobacterium | Major topic |
| Anti-Bacterial Agents | |
| Species Specificity |
Source PubMed
Cited by53
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 121 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42944141 | An Effective Diagnostic Approach for Successful Recovery from Mycobacterium avium Systemic Infection in a Basset Hound Dog. | Vet Sci | 2026 | https://conductscience.org/library/papers/42944141 | PubMed |
| 41859070 | Mutations in oxyR and oxyR-ahpC Interogenic Region in Isoniazid-Resistant Mycobacterium tuberculosis Clinical Isolates from Chongqing, China. | Infect Drug Resist | 2026 | https://conductscience.org/library/papers/41859070 | PubMed |
| 41510050 | Estimation of second line anti-tubercular drug susceptibility to Mycobacterium tuberculosis in clinical isolates. | Iran J Microbiol | 2025 | https://conductscience.org/library/papers/41510050 | PubMed |
| 41245813 | Therapeutic potential of 7-oxo-DHEA as an adjunctive host-directed therapy for pulmonary tuberculosis. | BBA Adv | 2025 | https://conductscience.org/library/papers/41245813 | PubMed |
| 37700866 | Unusually high clarithromycin resistance in Mycobacterium abscessus subsp. abscessus isolated from human gastric epithelium. | Front Microbiol | 2023 | https://conductscience.org/library/papers/37700866 | PubMed |
| 35883142 | First case of systemic fatal mycobacteriosis caused by Mycobacterium goodii in a pet Kenyan sand boa (Eryx colubrinus loveridgei). | BMC Vet Res | 2022 | https://conductscience.org/library/papers/35883142 | PubMed |
| 34277818 | Up-regulated long noncoding RNA AC007128.1 and its genetic polymorphisms associated with Tuberculosis susceptibility. | Ann Transl Med | 2021 | https://conductscience.org/library/papers/34277818 | PubMed |
| 34141437 | Performance of Wayne assay for detection of pyrazinamide resistance in Mycobacterium tuberculosis: a meta-analysis study. | New Microbes New Infect | 2021 | https://conductscience.org/library/papers/34141437 | PubMed |
| 32520212 | Frequency of genomic mutations mediating resistance of Mycobacterium tuberculosis isolates to rifampicin in Northern Morocco. | Rev Inst Med Trop Sao Paulo | 2020 | https://conductscience.org/library/papers/32520212 | PubMed |
| 32317266 | KatG as Counterselection Marker for Nontuberculous Mycobacteria. | Antimicrob Agents Chemother | 2020 | https://conductscience.org/library/papers/32317266 | PubMed |
| 32281986 | Risk factors for drug-resistant tuberculosis at a referral centre in Toronto, Ontario, Canada: 2010-2016. | Can Commun Dis Rep | 2020 | https://conductscience.org/library/papers/32281986 | PubMed |
| 31807033 | The Anti-Mycobacterial Activity Of Ag, ZnO, And Ag- ZnO Nanoparticles Against MDR- And XDR-Mycobacterium tuberculosis. | Infect Drug Resist | 2019 | https://conductscience.org/library/papers/31807033 | PubMed |
| 31262763 | Auranofin Activity Exposes Thioredoxin Reductase as a Viable Drug Target in Mycobacterium abscessus. | Antimicrob Agents Chemother | 2019 | https://conductscience.org/library/papers/31262763 | PubMed |
| 30202770 | Clofazimine in Nontuberculous Mycobacterial Infections: A Growing Niche. | Open Forum Infect Dis | 2017 | https://conductscience.org/library/papers/30202770 | PubMed |
| 30185901 | Dormant Mycobacterium tuberculosis converts isoniazid to the active drug in a Wayne's model of dormancy. | J Antibiot (Tokyo) | 2018 | https://conductscience.org/library/papers/30185901 | PubMed |
| 29891957 | Impact of nicotine replacement therapy as an adjunct to anti-tuberculosis treatment and behaviour change counselling in newly diagnosed pulmonary tuberculosis patients: an open-label, randomised controlled trial. | Sci Rep | 2018 | https://conductscience.org/library/papers/29891957 | PubMed |
| 29850302 | Chronic Tenosynovitis due to Mycobacteria kansasii in an Immunocompetent Host. | Case Rep Infect Dis | 2018 | https://conductscience.org/library/papers/29850302 | PubMed |
| 29780901 | Nocardial scleritis: A case report and a suggested algorithm for disease management based on a literature review. | Am J Ophthalmol Case Rep | 2018 | https://conductscience.org/library/papers/29780901 | PubMed |
| 28961957 | Identification of novel mutations associated with cycloserine resistance in Mycobacterium tuberculosis. | J Antimicrob Chemother | 2017 | https://conductscience.org/library/papers/28961957 | PubMed |
| 28886729 | Evaluation of Xpert MTB/RIF testing for rapid diagnosis of childhood pulmonary tuberculosis in children by Xpert MTB/RIF testing of stool samples in a low resource setting. | BMC Res Notes | 2017 | https://conductscience.org/library/papers/28886729 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/11073754
GET https://conductscience.org/api/papers/v1/11073754/cited_by?page=2